Searching News Database: Botulinum Toxin Type B
HSMN NewsFeed - 8 Feb 2008
Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
HSMN NewsFeed - 21 Dec 2007
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
HSMN NewsFeed - 11 Oct 2007
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
Additional items found! 4
Members Archive contains
4 additional stories matching:
Botulinum Toxin Type B
(Password required)
Botulinum Toxin Type B
(Password required)
